Biocross

e4Risk Quantitative

Biomarkers / Diagnostic
Central Nervous System
Determination of ApoE4 plasma quantification as a reliable predictor of pathological concentrations of Abeta peptide, Tau and phosphotau in cerebrospinal fluid of patients with clinical suspiction of Alzheimer´s Disease.
2Preclinical Validation, 1R+D